Alexandra Chera

Alexandra is an exceptional sixth year medical student passionate about the fields of Pathology, Genetics and with a special interest in new in vitro models of human diseases that can advance and impact our knowledge in diagnostic pathology and disease therapy.

She already has an excellent record of productivity and excellence, submitting two review article as the first author within the first two months of her activity in our laboratory:

Chera A et al. Thyroid-related adverse events induced by immune checkpoint inhibitors. Front. Endocrinology (IF. 6.05):

https://pubmed.ncbi.nlm.nih.gov/36204105/

Chera A et al. Remdesivir: the first FDA-approved anti-COVID-19 Treatment for Young Children. Discoveries 

https://pubmed.ncbi.nlm.nih.gov/36156901/

and having the third manuscript submitted as the 2nd author in Frontiers in Cell and Developmental Biology (IF 6).

We are honored to have her as one of our trainees and key members of our group!